Skip to main content

Table 4 Association of cardiovascular risk factors with OAP and/or OAC treatment

From: Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland

Risk factor OAP or OAC OAP OAC OAP and OAC
Pharmacologically treated hypertension 3.62 3.48 3.12 3.87
  (3 - 4.37) (2.88 - 4.21) (1.56 - 6.23) (0.46 - 32.58)
  p < 0.01 p < 0.01 p < 0.01 NS
Previus myocardial infarct 2.53 2.67 0.71 2.19
  (1.93 - 3.31) (2.06 - 3.45) (0.43 - 1.19) (0.8 - 5.95)
  p < 0.01 p < 0.01 NS NS
Previous stroke 2.84 2.19 2.31 0.38
  (2.11 - 3.83) (1.65 - 2.91) (1.35 - 3.96) (0.05 - 3.05)
  p < 0.01 p < 0.01 p < 0.01 NS
History of atrial fibrilation 1.54 0.95 9.01 1.64
  (1.25 - 1.89) (0.77 - 1.16) (5.74 - 14.14) (0.59 - 4.57)
  p < 0.01 NS p < 0.01 NS
Coronary heart disease (without myocardial infarct) 1.66 1.65 1.2 4.15
  (1.32 - 2.08) (1.32 - 2.05) (0.77 - 1.86) (1.47 - 11.71
  p < 0.01 p < 0.01 NS p = 0.01
Congestive heart failure 1.67 1.36 1.87 1.97
  (1.28 - 2.17) (1.06 - 1.76) (1.2 - 2.92) (0.69 - 5.63)
  p < 0.01 p = 0.02 p = 0.01 NS
Pharmacologically treated diabetes 1.22 1.23 0.91 0.34
  (1.02 - 1.47) (1.03 - 1.47) (0.6 - 1.4) (0.09 - 1.22)
  p = 0.03 p = 0.02 NS NS
Pharmacologically treated dyslipidaemia 2.77 2.5 1.84 3.61
  (2.32 - 3.31) (2.11 - 2.98) (1.22 - 2.76) (1.2 - 10.88)
  p < 0.01 p < 0.01 p < 0.01 p = 0.02
Current smoker 0.78 0.8 0.72 0.39
  (0.58 - 1.06) (0.6 - 1.09) (0.32 - 1.62) (0.05 - 3.28)
  NS NS NS NS
Previus smoker 0.92 0.97 0.61 0.32
  (0.76 - 1.11) (0.8 - 1.17) (0.38 - 0.97) (0.11 - 0.94)
  NS NS p = 0.04 p = 0.04
Overweight/obesity 0.91 0.82 2.44 1.44
  (0.75 - 1.09) (0.68 - 0.98) (1.33 - 4.5) (0.39 - 5.31)
(BMI ≥ 25 kg/m2) NS p = 0.03 p < 0.01 NS
Sex (male) 1.44 1.33 2.07 4.14
  (1.2 - 1.73) (1.11 - 1.6) (1.32 - 3.25) (1.34 - 12.78)
  p < 0.01 p < 0.01 p < 0.01 p = 0.01
  1. Data are presented as OR (95%CI) and p-value.
  2. OAP - Oral antiplatelet drugs, OAC - Oral anticoagulant drugs.